G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2002
10/22/2002	US6468762 High specificity homocysteinases
10/22/2002	US6468761 Microfluidic in-line labeling method for continuous-flow protease inhibition analysis
10/22/2002	US6468760 Antifungal assay
10/22/2002	US6468759 Detection of membrane conformational changes through detection of color changes in biopolymeric materials
10/22/2002	US6468757 Spectrofluorimetry
10/22/2002	US6468756 Methods of identifying compounds that bind to SNORF25 receptors
10/22/2002	US6468755 Method for identifying compounds for treatment of insulin resistance
10/22/2002	US6468753 Anthraquinone and its derivatives
10/22/2002	US6468752 Agent and method for detecting chemical substances
10/22/2002	US6468750 Cell regulation factor TTO 20
10/22/2002	US6468741 Electrochemiluminescent rhenium moieties
10/22/2002	US6468738 First polypeptide fused to a filamentous phage membrane cpviii anchor domain; mutating immunoglobulin variable domain-coding nucleotide sequence in the provided genome to form library of phage particles; immunoglobulin vh polypeptide (antibody heavy
10/22/2002	US6468737 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders
10/22/2002	US6468736 High efficiency cell analysis system and high throughput drug screening system
10/22/2002	US6468735 For rapidly screening compounds that inhibit angiogenesis;
10/22/2002	US6468734 Container for measurement of cell functions, kit for measurement of cell functions and method for measuring cell functions
10/22/2002	US6468546 Compositions and methods for therapy and diagnosis of ovarian cancer
10/22/2002	US6468538 Recombinant proteins for the fusion of the porcine reproductive and respiratory syndrome virus and its use in diagnosis
10/22/2002	US6468537 Nucleosome histone protein
10/22/2002	US6468533 Polyclonal or monoclonal antibody that inhibits high mobility group 1 protein mediated activation of inflammatory cytokine cascade; sepsis
10/22/2002	US6468530 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype
10/22/2002	US6468529 Fab fragment of a monoclonal antibody; binds to c-met receptor; cancer treatment
10/22/2002	US6468528 Materials and methods to inhibit Hodgkin and Reed Sternberg cell growth
10/22/2002	US6468476 Methods for using-co-regulated genesets to enhance detection and classification of gene expression patterns
10/22/2002	US6468474 Saliva testing and confirmation device
10/22/2002	US6468407 Protective coating comprises a mixture of a metal oxide, a zeolite, and an alumina is disposed on the protective layer adjacent to the sensing electrode.
10/22/2002	US6468222 Metabolic calorimeter employing respiratory gas analysis
10/22/2002	US6467950 Device and method to measure mass loss rate of an electrically heated sample
10/22/2002	US6467333 Trace level detection of analytes using artificial olfactometry
10/22/2002	US6467332 Device for olfactory judgment of an odorous substance, use thereof and a method of operating the device
10/22/2002	CA2216601C Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies
10/20/2002	CA2382660A1 Method of detecting lesions such as cancer and inflammation in a transgenic mouse incorporating cytokine 3' untranslated region, using the instability of mrna
10/20/2002	CA2382326A1 Therapeutic use of selective pde10 inhibitors
10/17/2002	WO2002082505A2 A method to reduce leakage during a semi-conductor burn-in procedure
10/17/2002	WO2002082264A2 A font for displaying genetic information
10/17/2002	WO2002082093A2 Methods to measure lipid antioxidant activity
10/17/2002	WO2002082092A2 Method for determining effective parathormone activity in a sample
10/17/2002	WO2002082091A2 Method for identification of proteins from intracellular bacteria
10/17/2002	WO2002082090A1 Methods of detecting specific cell lysis
10/17/2002	WO2002082089A2 Anti-idiotypic antibody and its use in diagnosis and therapy of hepatitis c virus related diseases
10/17/2002	WO2002082087A2 Diagnosis and treatment of enterococcus faecium related disease
10/17/2002	WO2002082086A2 Detection of methicillin-resistant staphylococcus aureus (mrsa)
10/17/2002	WO2002082085A2 Conditional autoimmune reaction by natural autoantibodies
10/17/2002	WO2002082084A1 Detection of biological pathway components
10/17/2002	WO2002082083A1 Electrophoresis
10/17/2002	WO2002082082A2 Fluorescence polarization assay
10/17/2002	WO2002082081A2 Suppression of androgen receptor transactivation through new pathways to ar and ar coactivators and repressors
10/17/2002	WO2002082080A2 Method for producing a plurality of identical copies of a two-dimensional test array of probe molecules
10/17/2002	WO2002082078A2 Activated enzyme-linked detection systems for detecting and quantifying nucleid acids, antigens antibodies and other analytes
10/17/2002	WO2002082077A2 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes
10/17/2002	WO2002082076A2 Renal cell carcinoma tumor markers
10/17/2002	WO2002082075A2 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents
10/17/2002	WO2002082068A1 Concentration cell type hydrogen sensor and method for preparing solid electrolyte capable of conducting proton
10/17/2002	WO2002082054A1 Long life fatigue strength design method for metallic material
10/17/2002	WO2002082052A2 Blood testing device
10/17/2002	WO2002082051A2 An integrated high throughput system for the analysis of biomolecules
10/17/2002	WO2002082048A2 Structure/properties correlation with membrane affinity profile
10/17/2002	WO2002082046A2 Silicon-wafer based devices and methods for analyzing biological material
10/17/2002	WO2002082045A2 Thin film sensor array for the detection of gases and a method of making
10/17/2002	WO2002082043A2 Transgenic zebrafish models for neurodegenerative diseases
10/17/2002	WO2002082041A2 Production and use of novel peptide-based agents for use with bi-specific antibodies
10/17/2002	WO2002082040A2 A 'one-device' system for testing constituents in fluids
10/17/2002	WO2002081754A1 Nucleic acid vaccines for prevention of flavivirus infection
10/17/2002	WO2002081752A2 Methods and kits useful for the simplification of complex peptide mixtures
10/17/2002	WO2002081749A2 Detection of aberrant dna methylation as marker for human cancer
10/17/2002	WO2002081747A1 Method of examining steroid responsiveness
10/17/2002	WO2002081742A2 Method for the detection of cytochrome b mutations in fungi
10/17/2002	WO2002081741A2 Use of products of genes of the 2'-5' oligoadenylate synthetase family (oas) for screening antiviral agents and for detecting responsiveness to flaviviridae infection
10/17/2002	WO2002081740A2 Supported double-layer structure for displaying a nucleic acid associated with a protein
10/17/2002	WO2002081735A2 Detection of negatively charged polymers using water-soluble, cationic, polythiophene derivatives
10/17/2002	WO2002081734A1 Methods for modeling infectious disease and chemosensitivity in cultured cells and tissues
10/17/2002	WO2002081733A1 Method of detecting and evaluating angiotensinogen receptor-modulating compounds using placental cells
10/17/2002	WO2002081732A1 Predicting taxonomic classification of drug targets
10/17/2002	WO2002081730A2 Trac1: modulators of lymphocyte activation
10/17/2002	WO2002081709A2 Modified hpv e6 and e7 genes and proteins useful for vaccination
10/17/2002	WO2002081691A2 Abcg5 and abcg8: compositions and methods of use
10/17/2002	WO2002081690A1 Novel protein, dna thereof and use of the same
10/17/2002	WO2002081683A2 Protein analysis by means of immobilized arrays of antigens or antibodies
10/17/2002	WO2002081681A1 Novel use of cytokine sf20
10/17/2002	WO2002081662A1 Methods and gel compositions for encapsulating living cells and organic molecules
10/17/2002	WO2002081646A2 Epitope sequences
10/17/2002	WO2002081642A2 Gene brcc-3 and diagnostic and therapeutic uses thereof
10/17/2002	WO2002081641A2 Gene scc-112 and diagnostic and therapeutic uses thereof
10/17/2002	WO2002081638A2 Prostate cancer expression profiles
10/17/2002	WO2002081636A2 Protein modification and maintenance molecules
10/17/2002	WO2002081630A2 Use of semenogelin in the diagnosis, prognosis and treatment of cancer
10/17/2002	WO2002081627A2 Methods of screening and using inhibitors of angiogenesis
10/17/2002	WO2002081523A2 Method for preparing and selecting antibodies
10/17/2002	WO2002081522A1 Anti-osteopontin antibody and use thereof
10/17/2002	WO2002081515A1 Insulin-like growth factor-binding protein
10/17/2002	WO2002081513A2 Disease-associated protein
10/17/2002	WO2002081504A2 Multimerization of hiv-1 vif protein as a therapeutic target
10/17/2002	WO2002081492A1 Human gene critical to fertility
10/17/2002	WO2002081490A2 Computer-directed assembly of a polynucleotide encoding a target polypeptide
10/17/2002	WO2002081476A1 Thiophosphate nucleic acid-based compounds
10/17/2002	WO2002081415A2 Method for inhibiting metap2
10/17/2002	WO2002081413A2 One dimensional unichemo protection (ucp) in organic synthesis
10/17/2002	WO2002081084A2 Microtiter plate format device and methods for separating differently charged molecules using an electric field
10/17/2002	WO2002080963A1 Methods of mhc class ii epitope mapping, detection of autoimmune t cells and antigens, and autoimmune treatment
10/17/2002	WO2002080960A2 Treatment of neuropathologies associated with expression of tnf-alpha

1 ... 2728 2729 2730 2731 2732 2733 2734 2735 2736 2737 2738 2739 2740 2741 2742 2743 2744 2745 2746 2747 2748 ... 3937